Under the conditions of the Heck reaction, 9-benzyl-6-iodopurine affords mainly the corresponding 6,6Ј-dimer, the Heck product being formed only in low yield (Յ12 %). With 7-benzyl-6-iodopurine the dimerization is suppressed and the Heck product is obtained in 32-91 % yield. 9-Substituted 6-chloro-2-iodopurines react smoothly, giving 2-alkenyl-6-
IntroductionAmong a vast number of biologically active purine derivatives, alkenylpurines play an important role.[1] 6-Alkenylpurines, for example, are associated with antimycobacterial, [2] cytotoxic [3] and cytokinin [4] activity and with inhibition of 15-lipoxygenase.[5] Some 6-alkenylpurines have been designed as covalent analogues of DNA base pairs [6] or novel cross-linking agents, [7] and have also been used for the synthesis of fluorescent nucleoside analogues.[8] Moreover, 2-alkenyladenosine derivatives have been reported to function as inhibitors of adenosine receptors. [9] Several methodologies have been used for the preparation of alkenylpurines. 6-Styrylpurine was first prepared by condensation of 6-methylpurine with benzaldehyde in the presence of HCl.[10] Another, more general, synthetic approach to 6-alkenylpurines, is based on Wittig reactions between 9-protected (purin-6-yl)methylene-triphenyl-λ 5 -phosphanes (Wittig reagents) and aldehydes or ketones.[11]Cyclic 6-alkenyloxypurines have been prepared by intramolecular cyclization of 6-(hydroxyalkyn-1-yl)purines, [12] while 6-enaminopurines are accessible by addition of amines to 6-alkynylpurines.[13] Partial hydrogenation of 2-alkynyl- [14] and 8-alkynylpurines [15] to give the corresponding alkenes has also been reported. Hydrogenation of 6-alkynylpurines to 6-alkenylpurines was reported to proceed satisfactorily only with 9-unprotected bases, with overhydrogenation taking place otherwise.[4a] However, the most versatile methodology for the preparation of alkenylpurines -nowadays used almost without exception -is based on transitionmetal-catalyzed cross-coupling reactions.[16] Alkenylpurines [a]